CLARUS THERAPEUTICS HLDGS INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Feb 14, 2023 12:29 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FYI Ltd.(.54%),Olifant Fund, Ltd.(.50%), etc.
Jul 6, 2022 16:00 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 9, 2022 20:06 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 9, 2022 20:04 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 9, 2022 20:02 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 9, 2022 20:02 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Jun 9, 2022 20:00 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Apr 27, 2022 16:09 ET
Clarus Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-10% Owner THOMAS MCNERNEY & PARTNERS LP
Apr 25, 2022 17:17 ET
Clarus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James E. Thomas(0.2%),Thomas, McNerney & Partners, LLC(0.1%), etc.
Apr 21, 2022 20:43 ET
Clarus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14, 2022 18:22 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(1.1%),Heights Capital Management, Inc.(1.1%)
Feb 14, 2022 15:24 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lighthouse Investment Partners, LLC(0%),MAP 136 Segregated Portfolio, a segregated portfolio of LMA SPC(0%), etc.
Feb 14, 2022 11:35 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bracebridge Capital, LLC(8.3%),FFI Fund Ltd.(6.1%), etc.
Feb 14, 2022 11:34 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Beryl Capital Management LLC(0%),Beryl Capital Management LP(0%), etc.
Feb 11, 2022 18:51 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hudson Bay Capital Management LP(0%),Sander Gerber(0%)
Feb 8, 2022 16:28 ET
Clarus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ANDREW M. WEISS, PH.D.(0.00%)
Feb 4, 2022 11:49 ET
Clarus Therapeutics | D: Filing D
Dec 21, 2021 08:59 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Dec 14, 2021 19:03 ET
Clarus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Dec 14, 2021 19:02 ET
No Data
No Data